|Articles|May 1, 2012
- Pharmaceutical Executive-05-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2012
Marooned at the Top
Advertisement
Articles in this issue
over 14 years ago
Pharma 50 Comment: Seeding Beyond the Baseover 14 years ago
Value-Based Pricing: Too High a Price for UK Pharma?over 14 years ago
Pharm Exec 50: Growth from the Bottom Upover 14 years ago
Country Report: South Africaover 14 years ago
Managing Information Overloadover 14 years ago
Super-Size Me: Optimizing the Information Explosionover 14 years ago
Government: Big Pharma's Best Friend in Emerging Markets?over 14 years ago
Information Overloadover 14 years ago
Pharma's Winning Innovative TechnologyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5